Reference
Towner M, et al. Ipilimumab and nivolumab for recurrent neuroendocrine cervical carcinoma. Gynecologic Oncology Reports 42: Aug 2022. Available from: URL: http://doi.org/10.1016/j.gore.2022.101039
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1953, 50 (2023). https://doi.org/10.1007/s40278-023-37485-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-37485-2